United Therapeutics (UTHR) Non Operating Income (2009 - 2026)
United Therapeutics (UTHR) posted Non Operating Income of -$7.5 million for Q1 2026, down 108.59% sequentially from $87.3 million in Q4 2025, and down 118.43% YoY from $40.7 million in Q1 2025.
United Therapeutics (UTHR) Non Operating Income (2009 - 2026) Analysis & Trends
United Therapeutics has reported Non Operating Income for 18 years, with the latest figure at -$7.5 million in Q1 2026.
- Quarterly Non Operating Income fell 118.43% year-over-year to -$7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173.2 million (up 7.98% YoY) and the FY2025 annual result came in at $221.4 million, up 36.67% from the prior year.
- Non Operating Income declined to -$7.5 million in Q1 2026 per UTHR's latest filing, from $87.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $87.3 million in Q4 2025 and troughed at -$51.2 million in Q2 2022.
- A 5-year average of $25.7 million and a median of $35.3 million in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income sank 798.25% in 2022, then soared 1477.78% in 2023.
- Over 5 years, Non Operating Income stood at $3.2 million in 2022, then surged by 1003.12% to $35.3 million in 2023, then advanced by 9.92% to $38.8 million in 2024, then soared by 125.0% to $87.3 million in 2025, then slumped by 108.59% to -$7.5 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$7.5 million, $87.3 million, and $49.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | -20.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.90 Mn |
| Mar 31, 2026 | -7.50 Mn |
| Dec 31, 2025 | 87.30 Mn |
| Sep 30, 2025 | 49.50 Mn |
| Jun 30, 2025 | 43.90 Mn |
| Mar 31, 2025 | 40.70 Mn |
| Dec 31, 2024 | 38.80 Mn |
| Sep 30, 2024 | 45.50 Mn |
| Jun 30, 2024 | 35.40 Mn |
| Mar 31, 2024 | 42.30 Mn |
| Dec 31, 2023 | 35.30 Mn |
| Sep 30, 2023 | 24.80 Mn |
| Jun 30, 2023 | 21.80 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -51.20 Mn |
| Mar 31, 2022 | 20.70 Mn |
| Dec 31, 2021 | -29.30 Mn |
| Sep 30, 2021 | -24.30 Mn |